Shannon O'Callaghan
Stock Analyst at Morgan Stanley
(1.2)
# 1422
Out of 5,291 analysts
40
Total ratings
52.17%
Success rate
13.37%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Guardant Health | Maintains: Overweight | 42 52 | 43.1 | 20.65% | 5 | Mar 6, 2025 | |
Fortive | Initiates Coverage On: Neutral | 84 | 72.57 | 15.75% | 6 | Nov 13, 2024 | |
Danaher | Maintains: Buy | 297 323 | 205.69 | 57.03% | 2 | Jul 28, 2022 | |
Pentair | Maintains: Neutral | 32 36 | 86.71 | -58.48% | 4 | May 8, 2020 | |
Gardner Denver Holdi... | Maintains: Buy | 37 38 | n/a | n/a | 4 | Jan 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Mar 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 5 | Jan 10, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 44 40 | 79.64 | -49.77% | 3 | Sep 11, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 180 190 | 210.36 | -9.68% | 2 | Aug 30, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 90 | 108.54 | -17.08% | 5 | Aug 30, 2018 |